Evaluate the Safety and Efficacy of CAR-T Cells in the Treatment of Refractory Myasthenia Gravis
Clinical trial NCT05828225 · UNKNOWN
Trial details
- NCT number
- NCT05828225
- Sponsor
- Zhejiang University
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-30
- Primary completion
- 2026-04-20
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.